Literature DB >> 30783789

Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.

Aiguo Han1, Yingzhen N Zhang2, Andrew S Boehringer2, Michael P Andre3, John W Erdman4, Rohit Loomba5, Claude B Sirlin2, William D O'Brien6.   

Abstract

OBJECTIVES: To assess inter-platform reproducibility of ultrasonic attenuation coefficient (AC) and backscatter coefficient (BSC) estimates in adults with known/suspected nonalcoholic fatty liver disease (NAFLD).
METHODS: This HIPAA-compliant prospective study was approved by an institutional review board; informed consent was obtained. Participants with known/suspected NAFLD were recruited and underwent same-day liver examinations with clinical ultrasound scanner platforms from two manufacturers. Each participant was scanned by the same trained sonographer who performed multiple data acquisitions in the right liver lobe using a lateral intercostal approach. Each data acquisition recorded a B-mode image and the underlying radio frequency (RF) data. AC and BSC were calculated using the reference phantom method. Inter-platform reproducibility was evaluated for AC and log-transformed BSC (logBSC = 10log10BSC) by intraclass correlation coefficient (ICC), Pearson's correlation, Bland-Altman analysis with computation of limits of agreement (LOAs), and within-subject coefficient of variation (wCV; applicable to AC).
RESULTS: Sixty-four participants were enrolled. Mean AC values measured using the two platforms were 0.90 ± 0.13 and 0.94 ± 0.15 dB/cm/MHz while mean logBSC values were - 30.6 ± 5.0 and - 27.9 ± 5.6 dB, respectively. Inter-platform ICC was 0.77 for AC and 0.70 for log-transformed BSC in terms of absolute agreement. Pearson's correlation coefficient was 0.81 for AC and 0.80 for logBSC. Ninety-five percent LOAs were - 0.21 to 0.13 dB/cm/MHz for AC, and - 9.48 to 3.98 dB for logBSC. The wCV was 7% for AC.
CONCLUSIONS: Hepatic AC and BSC are reproducible across two different ultrasound platforms in adults with known or suspected NAFLD. KEY POINTS: • Ultrasonic attenuation coefficient and backscatter coefficient are reproducible between two different ultrasound platforms in adults with NAFLD. • This inter-platform reproducibility may qualify quantitative ultrasound biomarkers for generalized clinical application in patients with suspected/known NAFLD.

Entities:  

Keywords:  Nonalcoholic fatty liver disease; Phantoms, imaging; Prospective studies; Reproducibility of results; Ultrasonography

Mesh:

Year:  2019        PMID: 30783789      PMCID: PMC6684824          DOI: 10.1007/s00330-019-06035-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

Review 1.  Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.

Authors:  Scott B Reeder; Irene Cruite; Gavin Hamilton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-09-16       Impact factor: 4.813

2.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

Authors:  Magali Sasso; Michel Beaugrand; Victor de Ledinghen; Catherine Douvin; Patrick Marcellin; Raoul Poupon; Laurent Sandrin; Véronique Miette
Journal:  Ultrasound Med Biol       Date:  2010-09-27       Impact factor: 2.998

Review 3.  Intraclass correlations: uses in assessing rater reliability.

Authors:  P E Shrout; J L Fleiss
Journal:  Psychol Bull       Date:  1979-03       Impact factor: 17.737

4.  Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

Authors:  Valerio Nobili; Francesco Vizzutti; Umberto Arena; Juan G Abraldes; Fabio Marra; Andrea Pietrobattista; Rodolfo Fruhwirth; Matilde Marcellini; Massimo Pinzani
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

5.  Backscatter coefficient measurements using a reference phantom to extract depth-dependent instrumentation factors.

Authors:  L X Yao; J A Zagzebski; E L Madsen
Journal:  Ultrason Imaging       Date:  1990-01       Impact factor: 1.578

6.  Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.

Authors:  Arian Mashhood; Radha Railkar; Takeshi Yokoo; Yakir Levin; Lisa Clark; Sabrina Fox-Bosetti; Michael S Middleton; Jonathan Riek; Eunkyung Kauh; Bernard J Dardzinski; Donald Williams; Claude Sirlin; Norah J Shire
Journal:  J Magn Reson Imaging       Date:  2012-11-21       Impact factor: 4.813

7.  Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Authors:  Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

8.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

9.  Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse.

Authors:  Nathan S Artz; Catherine D G Hines; Stephen T Brunner; Rashmi M Agni; Jens-Peter Kühn; Alejandro Roldan-Alzate; Guang-Hong Chen; Scott B Reeder
Journal:  Invest Radiol       Date:  2012-10       Impact factor: 6.016

10.  Intra- and interoperator reproducibility of acoustic radiation force impulse (ARFI) elastography--preliminary results.

Authors:  Simona Bota; Ioan Sporea; Roxana Sirli; Alina Popescu; Mirela Danila; Dan Costachescu
Journal:  Ultrasound Med Biol       Date:  2012-05-12       Impact factor: 2.998

View more
  8 in total

1.  Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.

Authors:  Aiguo Han; Yingzhen N Zhang; Andrew S Boehringer; Vivian Montes; Michael P Andre; John W Erdman; Rohit Loomba; Mark A Valasek; Claude B Sirlin; William D O'Brien
Journal:  Radiology       Date:  2020-02-04       Impact factor: 11.105

2.  A Phantom-Based Assessment of Repeatability and Reproducibility of Transvaginal Quantitative Ultrasound.

Authors:  Shi Chen; Barbara L McFarlin; Barbara T Meagher; Tara A Peters; Douglas G Simpson; William D O'Brien; Aiguo Han
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2019-06-14       Impact factor: 2.725

Review 3.  Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.

Authors:  Nobuharu Tamaki; Veeral Ajmera; Rohit Loomba
Journal:  Nat Rev Endocrinol       Date:  2021-11-23       Impact factor: 47.564

Review 4.  SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease.

Authors:  Luigi Mirarchi; Simona Amodeo; Roberto Citarrella; Anna Licata; Maurizio Soresi; Lydia Giannitrapani
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

5.  Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease.

Authors:  Sun Kyung Jeon; Jeong Min Lee; Ijin Joo; Jeong Hee Yoon
Journal:  Ultrasonography       Date:  2021-10-31

6.  Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.

Authors:  Aiguo Han; Michal Byra; Elhamy Heba; Michael P Andre; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  Radiology       Date:  2020-02-25       Impact factor: 29.146

Review 7.  Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease.

Authors:  Amir M Pirmoazen; Aman Khurana; Ahmed El Kaffas; Aya Kamaya
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

8.  Transfer learning radiomics based on multimodal ultrasound imaging for staging liver fibrosis.

Authors:  Li-Yun Xue; Zhuo-Yun Jiang; Tian-Tian Fu; Qing-Min Wang; Yu-Li Zhu; Meng Dai; Wen-Ping Wang; Jin-Hua Yu; Hong Ding
Journal:  Eur Radiol       Date:  2020-01-21       Impact factor: 5.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.